Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Hou

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
The American Journal of Gastroenterology|December 12, 2022
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's DiseaseMichael D Kappelman, Sruthi Adimadhyam, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CMMara M Epstein, Sarah K Dutcher, Judith C Maro, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
The American Journal of Gastroenterology|December 12, 2022
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's DiseaseMichael D Kappelman, Sruthi Adimadhyam, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CMMara M Epstein, Sarah K Dutcher, Judith C Maro, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pageof 3